It’s very impressive data. For triple negative n
Post# of 36537
(Total Views: 290)
Posted On: 04/28/2020 11:51:02 AM
It’s very impressive data. For triple negative n = 21. So yes they need a larger subject and control group. And they also now treat with keytruda. So I think they’ll find success. (See graph bottom second from left)
https://link.springer.com/article/10.1007/s10.../figures/5
https://link.springer.com/article/10.1007/s10.../figures/5
(1)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼